InVivo Therapeutics to price public offering of common-share units

Proceeds finance research and development, working capital needs

By Devika Patel

Knoxville, Tenn., Dec. 16 - InVivo Therapeutics Holdings Corp. will price a public offering of units, according to a prospectus supplement filed Friday with the Securities and Exchange Commission.

The company will sell units of common shares and 10-year warrants.

Proceeds will be used for research and development, working capital needs, capital expenditures and other general corporate purposes.

Based in Cambridge, Mass., the company is focused on technologies for spinal cord injuries.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.